Neville M. Davidson

Birmingham, ENG B152TT, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Characteristics of Restart a Heart 2019 event locations in the UK.

Characteristics of Restart a Heart 2019 event locations in the UK.

Journal: Resuscitation plus

Published: December 30, 2020

Measurement of the fluorescence lifetime of GFP in high refractive index levitated droplets using FLIM.

Measurement of the fluorescence lifetime of GFP in high refractive index levitated droplets using FLIM.

Journal: Physical chemistry chemical physics : PCCP

Published: June 24, 2020

Palbociclib and endocrine therapy in heavily pretreated hormone receptor-positive HER2-negative advanced breast cancer: the UK Compassionate Access Programme experience.

Palbociclib and endocrine therapy in heavily pretreated hormone receptor-positive HER2-negative advanced breast cancer: the UK Compassionate Access Programme experience.

Journal: Breast cancer research and treatment

Published: January 07, 2019

Measurement of the Raman spectra and hygroscopicity of four pharmaceutical aerosols as they travel from pressurised metered dose inhalers (pMDI) to a model lung.

Measurement of the Raman spectra and hygroscopicity of four pharmaceutical aerosols as they travel from pressurised metered dose inhalers (pMDI) to a model lung.

Journal: International journal of pharmaceutics

Published: October 24, 2016

Fluorescence lifetime imaging of optically levitated aerosol: a technique to quantitatively map the viscosity of suspended aerosol particles.

Fluorescence lifetime imaging of optically levitated aerosol: a technique to quantitatively map the viscosity of suspended aerosol particles.

Journal: Physical chemistry chemical physics : PCCP

Published: July 20, 2016

Cloud condensation nucleation activities of calcium carbonate and its atmospheric ageing products.

Cloud condensation nucleation activities of calcium carbonate and its atmospheric ageing products.

Journal: Physical chemistry chemical physics : PCCP

Published: November 19, 2015

Adjuvant bevacizumab in patients with melanoma at high risk of recurrence (AVAST-M): preplanned interim results from a multicentre, open-label, randomised controlled phase 3 study.

Adjuvant bevacizumab in patients with melanoma at high risk of recurrence (AVAST-M): preplanned interim results from a multicentre, open-label, randomised controlled phase 3 study.

Journal: The Lancet. Oncology

Published: April 22, 2014

Perioperative management of patients on new oral anticoagulants.

Perioperative management of patients on new oral anticoagulants.

Journal: The British journal of surgery

Published: January 31, 2014

Phase II pilot study of intravenous high-dose interferon with or without maintenance treatment in melanoma at high risk of recurrence.

Phase II pilot study of intravenous high-dose interferon with or without maintenance treatment in melanoma at high risk of recurrence.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: December 18, 2013

Substituting Doxorubicin with nonpegylated liposomal Doxorubicin for the treatment of early breast cancer: results of a retrospective study.

Substituting Doxorubicin with nonpegylated liposomal Doxorubicin for the treatment of early breast cancer: results of a retrospective study.

Journal: International journal of breast cancer

Published: October 01, 2013

Adjuvant ganglioside GM2-KLH/QS-21 vaccination versus observation after resection of primary tumor > 1.5 mm in patients with stage II melanoma: results of the EORTC 18961 randomized phase III trial.

Adjuvant ganglioside GM2-KLH/QS-21 vaccination versus observation after resection of primary tumor > 1.5 mm in patients with stage II melanoma: results of the EORTC 18961 randomized phase III trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: September 11, 2013

Phase III trial of sunitinib in combination with capecitabine versus capecitabine monotherapy for the treatment of patients with pretreated metastatic breast cancer.

Phase III trial of sunitinib in combination with capecitabine versus capecitabine monotherapy for the treatment of patients with pretreated metastatic breast cancer.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: July 17, 2013

Showing 1-12 of 15

Last Updated: 09/26/2026